Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from High-Throughput Morphological Profiling of Patient-Derived Human Liver Organoids for Hepatotoxicity Hazard Identification and Compound Prioritization. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1007/s00204-020-02885-1
10.1007/s00204-020-02885-1 · External reference
10.1002/hep.23937
10.1002/hep.23937 · External reference
10.1177/17562848231163410
10.1177/17562848231163410 · External reference
Advances in engineered liver models for investigating drug-induced liver injury
2016 · External reference
10.1016/j.jss.2012.11.051
10.1016/j.jss.2012.11.051 · External reference
Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms
10.1016/j.tox.2021.152840 · 2021 · External reference
10.1016/j.cmet.2019.05.007
10.1016/j.cmet.2019.05.007 · External reference
10.1016/bs.mcb.2020.03.009
10.1016/bs.mcb.2020.03.009 · External reference
10.1053/j.gastro.2020.10.002
10.1053/j.gastro.2020.10.002 · External reference
10.1016/j.jhep.2023.01.019
10.1016/j.jhep.2023.01.019 · External reference
10.1016/j.gastha.2024.08.004
10.1016/j.gastha.2024.08.004 · External reference
The OASIS Consortium: integrating multi-omics technologies to transform chemical safety assessment
10.1093/toxsci/kfaf128 · 2025 · External reference
10.1101/2025.01.22.634152
10.1101/2025.01.22.634152 · External reference
10.1053/j.gastro.2015.03.006
10.1053/j.gastro.2015.03.006 · External reference
10.1038/nature13863
10.1038/nature13863 · External reference
10.1124/jpet.109.156331
10.1124/jpet.109.156331 · External reference
Sulindac-associated hepatic injury: analysis of 91 cases reported to the Food and Drug Administration
10.1016/0016-5085(93)90428-f · 1993 · External reference
10.1096/fasebj.23.1_supplement.741.5
10.1096/fasebj.23.1_supplement.741.5 · External reference
10.1016/j.jhep.2010.11.006
10.1016/j.jhep.2010.11.006 · External reference
10.1016/0163-7258(95)00012-6
10.1016/0163-7258(95)00012-6 · External reference
Freeze-fracture studies of cytoplasmic inclusions occurring in experimental lipidosis as induced by amphiphilic cationic drugs
10.1016/0005-2760(79)90132-2 · 1979 · External reference
10.1126/science.abi4708
10.1126/science.abi4708 · External reference
10.1177/019262339702500111
10.1177/019262339702500111 · External reference
10.1002/hep.23588
10.1002/hep.23588 · External reference
10.1073/pnas.93.8.3592
10.1073/pnas.93.8.3592 · External reference
Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity
10.1016/s0022-3565(24)37925-x · 1999 · External reference
Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis
10.1016/s0022-3565(24)37177-0 · 1997 · External reference
10.1021/tx100131f
10.1021/tx100131f · External reference
10.1007/s00204-017-2002-1
10.1007/s00204-017-2002-1 · External reference
10.1093/toxsci/kfv152
10.1093/toxsci/kfv152 · External reference
10.1016/j.tiv.2015.09.019
10.1016/j.tiv.2015.09.019 · External reference
10.1093/toxsci/kfn109
10.1093/toxsci/kfn109 · External reference
10.1007/s10565-011-9208-4
10.1007/s10565-011-9208-4 · External reference
Unresolved reference
External reference
10.1001/archderm.1970.04000120031005
10.1001/archderm.1970.04000120031005 · External reference
10.1002/art.1780290702
10.1002/art.1780290702 · External reference
Methotrexate and histologic hepatic abnormalities: a meta-analysis
10.1016/s0002-9343(05)80060-9 · 1991 · External reference
10.1016/b978-0-12-387817-5.00032-7
10.1016/b978-0-12-387817-5.00032-7 · External reference
Studies of the absorption and removal of propranolol in hypertensive patients during therapy
10.1161/01.cir.52.2.313 · 1975 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Drug-induced steatohepatitis
10.1080/17425255.2017.1246534 · 2017 · External reference
Unresolved reference
External reference
10.1038/nmeth.1591
10.1038/nmeth.1591 · External reference
10.1016/j.pep.2006.04.008
10.1016/j.pep.2006.04.008 · External reference
Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports
10.1002/hep.28323 · 2016 · External reference
10.1056/nejm199510263331702
10.1056/nejm199510263331702 · External reference
Unresolved reference
External reference
DILIrank 2.0: An updated and expanded database for drug-induced liver injury risk based on FDA labeling and a literature review
10.1016/j.drudis.2025.104485 · 2025 · External reference
10.1016/j.drudis.2019.09.022
10.1016/j.drudis.2019.09.022 · External reference
Best practices for cell painting morphologic profiling – every cell in focus
10.1093/mictod/qaae099 · 2024 · External reference
10.1371/journal.pbio.2005970
10.1371/journal.pbio.2005970 · External reference
10.1186/s12859-021-04344-9
10.1186/s12859-021-04344-9 · External reference
10.1186/gb-2006-7-10-r100
10.1186/gb-2006-7-10-r100 · External reference
10.1038/s41592-025-02611-8
10.1038/s41592-025-02611-8 · External reference